NCT02111031View on ClinicalTrials.gov

Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Metastatic Breast CancerBreast Cancer
Trial Locations (2)

19104

Abramson Cancer Center, University of Pennsylvania, Philadelphia

19107

Thomas Jefferson University, Philadelphia

Sponsors
All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

lead

Janssen Diagnostics, LLC

INDUSTRY